Let's assume no funny business even.
Greentech is now trading at something like A$225m EV.
We are trading at $110m EV.
If we compare on a FCF basis for that to make sense we would need to assume Greentech are making 2x MLX FCF. The point where that occurs is roughly double our C+M bill or 33.6m FCF - so $67m for 100% basis of Renison.
However we have done the numbers on what Renison Area 5 could look like.
800kt x 2% x 74% = 11,840t of contained Sn.
Your doc from earlier had Sn conc selling on MB for circa US$18kt but I will leave that for now.
Let's assume A$24k as it is currently. AISC of $13,000. Given current $16,000 and we are taking a good bump in grade.
Would give us 11k x 5,920t (our 50% share) = A$65m
So Greentech would be trading on 3.5x FCF.
If we also used 3.5x FCF we should be trading at A$168m even accounting for Nifty C+M costs.
Big arbitrage in my opinion. The more bullish you are Renison the more that becomes apparent.
- Forums
- ASX - By Stock
- MLX
- Ann: Board Resignations and Appointments
MLX
metals x limited
Add to My Watchlist
1.87%
!
54.5¢

Ann: Board Resignations and Appointments, page-34
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
54.5¢ |
Change
0.010(1.87%) |
Mkt cap ! $483.0M |
Open | High | Low | Value | Volume |
53.5¢ | 55.0¢ | 53.5¢ | $2.794M | 5.170M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
5 | 66317 | 54.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
54.5¢ | 124399 | 4 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
3 | 60817 | 0.540 |
3 | 82398 | 0.535 |
4 | 128434 | 0.530 |
3 | 159000 | 0.525 |
17 | 299620 | 0.520 |
Price($) | Vol. | No. |
---|---|---|
0.545 | 119999 | 3 |
0.550 | 276569 | 7 |
0.555 | 68173 | 4 |
0.560 | 50000 | 1 |
0.565 | 76718 | 2 |
Last trade - 16.10pm 26/06/2025 (20 minute delay) ? |
Featured News
MLX (ASX) Chart |
The Watchlist
PTX
PRESCIENT THERAPEUTICS LIMITED
James McDonnell, CEO
James McDonnell
CEO
Previous Video
Next Video
SPONSORED BY The Market Online